Search Results - "Zapf, Jim"
-
1
ViruClear: Molecularly designed biomimetic nanosponges for prevention and treatment of SARS‐CoV‐2 infections in COVID‐19 patients
Published in The FASEB journal (01-05-2021)“…The current COVID‐19 pandemic infectious disease agent SARS‐CoV‐2, like its’ cousin SARS‐CoV, uses a variety of entry receptors including angiotensin…”
Get full text
Journal Article -
2
A human stem cell phenotypic drug screening assay for identification of opioid and non‐opioid analgesics with lowered risk of addiction
Published in The FASEB journal (01-05-2021)“…Mu opioid receptors, a subclass of G protein‐coupled receptors (GPCRs), are involved in the control of pain perception and reward properties. They are also the…”
Get full text
Journal Article -
3
Countermeasures for Preventing and Treating Opioid Overdose
Published in Clinical pharmacology and therapeutics (01-03-2021)“…The only medication available currently to prevent and treat opioid overdose (naloxone) was approved by the US Food and Drug Administration (FDA) nearly…”
Get full text
Journal Article -
4
-
5
VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease
Published in Inflammopharmacology (01-04-2020)“…Introduction Retinoic Acid Related Orphan Nuclear Receptor gamma T (RORγT) is a lineage specifying transcription factor for IL-17 expressing cells, which may…”
Get full text
Journal Article -
6
107 - A Novel ROR-Gamma T Inhibitor (VPR-254) Attenuates Key Parameters of Innate Immune Colitis in Mice
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2017)Get full text
Journal Article -
7
A Novel ROR-Gamma T Inhibitor (VPR-254) Attenuates Key Parameters of Innate Immune Colitis in Mice
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2017)Get full text
Journal Article -
8
90 Efficacy of a Novel Small Molecule RORgt Inverse Agonist in Mouse DSS and TNBS Models of Inflammatory Bowel Disease
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2015)Get full text
Journal Article